Skip to main content
FinSpry Logo
FinSpry
RAPP logo
RAPP
(NASDAQ)
Rapport Therapeutics, Inc.
$41.38-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Rapport Therapeutics (RAPP) Stock Price & Financial Analysis

Rapport Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$40.00 - $41.74
52-Week High$44.28
52-Week Low$13.62
Open$40.53
Volume228.62K
Average Volume (3M)442.11K
Market Cap1.95B
Shares Outstanding47.24M
Price to Sales (P/S)97.73
Price to Book (P/B)4.15
EV/EBITDA-15.57
Revenue (TTM)20.00M
Net Income (TTM)-107.28M
Free Cash Flow (TTM)-80.71M
EPS (TTM)$-2.56
Profit Margin-536.39%
Operating Margin-611.03%
Return on Equity (ROE)-22.75%
Debt to Equity0.02
50-Day MA$38.68
200-Day MA$31.66
52-Week Change166.97%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Rapport Therapeutics

What is the current stock price for RAPP?

As of the latest trading session, RAPP stock trades at $41.38. The 52-week range is $13.62–$44.28, with a day range of $40.00–$41.74.

What is the P/E ratio for RAPP?

The P/E ratio (Price-to-Earnings) for RAPP is shown in the Key Statistics section. This valuation metric helps compare Rapport Therapeutics, Inc. to industry peers.

Does RAPP pay dividends?

Rapport Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RAPP?

Based on 6 analysts, the consensus for RAPP is Buy.

What is the market cap of RAPP?

Rapport Therapeutics's market capitalization is $1.95B, classifying it as a small-cap company. Rapport Therapeutics operates in the Healthcare sector within the Biotechnology industry.